Stay updated with breaking news from Analytical Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PerkinElmer (NYSE:PKI – Get Rating) had its target price reduced by Barclays from $140.00 to $125.00 in a research report released on Friday morning, The Fly reports. Several other analysts have also weighed in on PKI. Credit Suisse Group restated a neutral rating and set a $160.00 price target on shares of PerkinElmer in a […]
PerkinElmer (NYSE:PKI – Get Rating) had its target price decreased by Stifel Nicolaus from $145.00 to $135.00 in a report released on Friday morning, The Fly reports. A number of other research analysts have also weighed in on PKI. Barclays dropped their target price on PerkinElmer from $140.00 to $125.00 in a report on Friday. […]
PerkinElmer (NYSE:PKI – Get Rating) had its price objective reduced by Robert W. Baird from $182.00 to $165.00 in a research note published on Friday, The Fly reports. Other research analysts have also issued research reports about the stock. Barclays cut their target price on shares of PerkinElmer from $140.00 to $125.00 in a research […]
Achmea Investment Management B.V. trimmed its holdings in PerkinElmer, Inc. (NYSE:PKI – Get Rating) by 61.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,963 shares of the medical research company’s stock after selling 20,492 shares during the quarter. Achmea Investment Management B.V.’s […]
PerkinElmer (NYSE:PKI – Get Rating) updated its FY 2023 earnings guidance on Friday. The company provided earnings per share guidance of $4.85-$5.05 for the period, compared to the consensus earnings per share estimate of $5.16. The company issued revenue guidance of $2.90 billion-$2.94 billion, compared to the consensus revenue estimate of $3.15 billion. Analysts Set […]